Steven C. Borkan receives the NIH RO-1 Grant to Study Ischemic AKI
Dr. Borkan receives the NIH RO-1 award entitled: “Nucleophosmin Centered Diagnostics & Treatment of Ischemic Acute Kidney Injury”. The primary objective of his study is to harness nucleophosmin, a key cell death protein, as a potential rapid diagnostic and effective therapeutic target for ischemic AKI in our patients.
Weining Lu is recognized as the BU Innovator of the Year
Dr. Weining Lu is named the BU Innovator of the Year for 2019. Dr. Lu’s research on ROBO2 gene and his longstanding collaboration with Pfizer has led to the development of a potential new drug for chronic kidney disease that is currently in phase 2 clinical trials.
Larry Beck receives the ASN’s Distinguished Researcher Award
Dr. Laurence H. Beck Jr. receives the 2019 Distinguished Researcher Award by the American Society of Nephrology. This award recognizes individuals who have made substantial research contributions to the discipline of nephrology, and who have displayed innovation and excellence in research to advance the science and/or practice of nephrology. Drs. Beck and Salant’s discovery of […]